期刊文献+

B型利钠肽在心力衰竭治疗中的临床意义 被引量:2

原文传递
导出
摘要 【目的】探讨血浆B型利钠肽(BNP)水平在心力衰竭治疗中的临床价值。【方法】随机抽取98例慢性充血性心力衰竭(CHF)住院患者(其中心功能Ⅱ级28例,Ⅲ级30例,Ⅳ级40例)及无心衰患者35例(对照组),心袁患者临床给予常规控制心衰治疗2周,采用酶联免疫法检测BNP水平、超声心电图检测左室射血分数(LVEF)。比较两组BNP的水平及其与临床因素的关系。【结果】治疗前治疗组与对照组相比,BNP的水平显著升高(P〈0.05),而且随着心功能分级升高而升高。与治疗前相比,心衰各组治疗后BNP的水平显著下降(P〈0.05)。血浆BNP浓度明显增高的患者疗效欠佳。【结论】血浆BNP浓度对CHF患者的病情和治疗效果评估具有重要临床意义。
出处 《医学临床研究》 CAS 2012年第9期1807-1808,共2页 Journal of Clinical Research
  • 相关文献

参考文献7

  • 1孙同文,杨海波.B型利钠肽与心功能不全的诊断、预后评估及治疗[J].河南医学研究,2004,13(4):377-380. 被引量:12
  • 2Talwar S,Downie PF,Ng LL, et al . Towards a blood test for heart failure: the potential use of circulating natriuretic pep- tidea[J]. Br J Clin Pharmacol , 2000,50 (1) : 15-20.
  • 3Harrison A. B-type natriuretie peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea[J]. Ann Emerg Med ,2002,39(2) : 131-138.
  • 4卢飞舟,赵殿有.充血性心力衰竭患者血浆脑利钠肽浓度与心功能的关系[J].1心脏杂志,2004,16(3):266.
  • 5Shapiro BP, Chen HH, Burnett JC Jr, et al. Use of plasm brain natriuretic peptide concentration to aid in the diagnosis of heart failure[J]. Mayo Clin Proc ,2003,5(7) :481-486.
  • 6Latini R,Masson S,de Angelis N, et al . Rode of brain natri- curetic peptide in the diagnosis and management of heart fail- ure:Current concepts[J]. J Card Fail ,2002,8(4) :288-299.
  • 7Doust J, Lehman R, Glasziou P. The role of BNP testing in heart failure[J]. Am Faro Physician , 2006,7 (ll) : 1893-1898.

二级参考文献22

  • 1Cowie MR,Mendez GF.BNP and congestive heart failure.Prog Cardio DiS.2002,44(6):293-321.
  • 2Cowie MR,Struthers AD,Wood DA,et al.Value of natriuretic peptide in assessment of patients with possible new heart failure in primary care[J].Lancent,1997,350(9088):1349-1353.
  • 3Vallin N, GeorgesA, Corcuff JB, et al. Assessment of brain natriuretic peptide in patients with suspected heart failure:comparison with radionuclide ventriculography data[J]. Clin Chim Acta, 2001,306(1-2):19-26.
  • 4Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med, 2002,347(3):161-167.
  • 5Maisel AS, koon J, Krishnaswamy P,et al. Utility of B-type natriuretic peptide as a rapid,point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction[J]. Am Heart J,2001,141(3):367-374.
  • 6Lubien E, DeMeriaA, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction:comparison with Dopplor velocity recordings[J]. Circulation, 2002,105(5):595-601.
  • 7Ishii J, Nomura M, Ito M, et al. Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and fmortality in chronic respiratory disease[J]. Clin Chim Atca, 2000,301(1-2):19-30.
  • 8Denis MG, Eberle MC, Boudousq V , et al. Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure[J]. Eur J Heart Fail, 2003,5(4):481-488.
  • 9Yu CM, Sanderson JE. Plasma brain natriuretic peptide-an independent predictor of cardiovascular mortality in acute heart failure[J]. Eur J Heart Fail,1999,1(1):59-65.
  • 10Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction[J]. Circulation, 1997,96(2):509-516.

共引文献11

同被引文献22

引证文献2

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部